Surrozen (SRZN) Revenue (2024 - 2026)

Surrozen (SRZN) recorded quarterly Revenue of $5.0 million in Q1 2026, up 846.97% quarter-over-quarter from $528000.0 in Q4 2025, and up 408.65% on a YoY basis from $983000.0 in Q1 2025.

Surrozen (SRZN) Revenue (2024 - 2026) Analysis & Trends

Surrozen's Revenue history runs 3 years deep, the most recent figure standing at $5.0 million for Q1 2026.

  • In Q1 2026, Revenue rose 408.65% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $7.5 million (down 35.61% YoY), while the FY2025 annual figure was $3.5 million, down 67.37% from the prior year.
  • Revenue was $5.0 million for Q1 2026 at Surrozen, up from $528000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $10.0 million in Q3 2024 to a low of $528000.0 in Q4 2025.
  • Historically, Revenue has averaged $2.7 million across 3 years, with a median of $983000.0 in 2025.
  • The sharpest annual moves came in 2025 and 2026: Revenue tumbled 90.17% in 2025, then jumped 408.65% in 2026.
  • A 3-year view of Revenue shows it stood at $655000.0 in 2024, then declined by 19.39% to $528000.0 in 2025, then jumped by 846.97% to $5.0 million in 2026.
  • The last three Revenue figures came in at $5.0 million (Q1 2026), $528000.0 (Q4 2025), and $983000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 5.21 Mn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 306.30 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 2.99 Bn
9 Abivax 94.37 Bn 94.37 Bn - -
10 Surrozen 225,877.86 -106.68 Mn - 5.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.00 Mn
Dec 31, 2025 528,000.00
Sep 30, 2025 983,000.00
Jun 30, 2025 983,000.00
Mar 31, 2025 983,000.00
Dec 31, 2024 655,000.00
Sep 30, 2024 10.00 Mn